Get the Stockscreener App
7.83
0.25%
-0.02
After Hours:
7.83
Acrivon Therapeutics Inc Stock (ACRV) Forecast
The Acrivon Therapeutics Inc (ACRV) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.0587, representing a -86.48% decrease from the current price of $7.83. The highest analyst price target is $1.9177, and the lowest is $0.1996.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ACRV Price Target
Average 6.2981
(-19.56% Downside)
Is Acrivon Therapeutics Inc (ACRV) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.71 | Neutral |
| STOCH(9,6) | 40.55 | Neutral |
| STOCHRSI(14) | 11.99 | Buy |
| MACD(12,26) | 0.1068 | Sell |
| ADX(14) | 25.89 | Buy |
| William %R | -71.59 | Neutral |
| CCI(14) | -157.20 | Sell |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.053
Sell
|
7.9684
Sell
|
| MA20 |
7.831
Sell
|
7.8762
Sell
|
| MA50 |
7.8964
Sell
|
7.8103
Buy
|
| MA100 |
7.665
Buy
|
7.7204
Buy
|
| MA200 |
7.1464
Buy
|
7.738
Buy
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, ACRV could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on ACRV, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 49.71 indicates that ACRV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 40.55 indicates that ACRV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 11.99 indicates that ACRV is oversold. This suggests that ACRV price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.89 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -157.2 indicates that ACRV is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term ACRV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Acrivon Therapeutics Inc financial reports and earnings history, Acrivon Therapeutics Inc (ACRV) stock could reach $34.25 by 2030, $137.38 by 2040 and $134.34 by 2050. See the projected annual prices until 2050 of the Acrivon Therapeutics Inc stock below:
- Acrivon Therapeutics Inc (ACRV) is expected to reach an average price of $78.30 in 2035, with a high prediction of $82.25 and a low estimate of $78.50. This indicates an $900.02% rise from the last recorded price of $7.83.
- Acrivon Therapeutics Inc (ACRV) stock is projected to chart a bullish course in 2040, with an average price target of $139.33, representing an $1,679% surge from its current level. The forecast ranges from a conservative $138.05 to a sky-high $137.38.
- Our analysts predict Acrivon Therapeutics Inc (ACRV) to jump 944.09% by 2045, soaring from $82.90 to an average price of $81.75, potentially reaching $87.88. While $82.90 is the low estimate, the potential upside is significant.
- Acrivon Therapeutics Inc (ACRV) stock is expected to climb by 2050, reaching an average of $129.72, a $1,557% jump from its current level. However, a wide range of estimates exists, with high and low targets of $134.34 and $129.79, respectively, highlighting the market's uncertainty.
Acrivon Therapeutics Inc Stock (ACRV) Year by Year Forecast
Acrivon Therapeutics Inc Stock (ACRV) Price Forecast for 2024
Our forecast for ACRV stock price in 2024 now indicates an average price target of $6.0244 with a high forecast of $11.90 and a low forecast of $0.1488. The average prediction reflects an decrease of -23.06% from the last recorded price of $7.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $2.3485 | $0.1996 | $1.9177 | -70.01% |
Acrivon Therapeutics Inc Stock (ACRV) Price Forecast for 2025
Acrivon Therapeutics Inc Stock (ACRV) is expected to reach an average price of $6.372 in 2025, with a high prediction of $12.40 and a low estimate of $0.3473. This indicates an -18.62% fall from the last recorded price of $7.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.5242 | $2.9211 | $2.773 | -54.99% |
| February, 2025 | $3.0818 | $3.4018 | $3.3436 | -60.64% |
| March, 2025 | $2.1643 | $2.3243 | $1.9962 | -72.36% |
| April, 2025 | $2.925 | $2.5725 | $2.6159 | -62.64% |
| May, 2025 | $2.2776 | $2.7176 | $2.3932 | -70.91% |
| June, 2025 | $0.4299 | $0.7538 | $1.0399 | -94.51% |
| July, 2025 | $4.1392 | $0.3473 | $6.5473 | -47.14% |
| August, 2025 | $3.54 | $2.6511 | $5.1211 | -54.79% |
| September, 2025 | $14.35 | $10.82 | $12.40 | +83.21% |
| October, 2025 | $8.8865 | $9.2928 | $10.78 | +13.49% |
| November, 2025 | $8.3816 | $8.7916 | $8.599 | +7.04% |
| December, 2025 | $7.463 | $7.5204 | $7.9904 | -4.69% |
Acrivon Therapeutics Inc Stock (ACRV) Price Forecast for 2026
The predicted value for Acrivon Therapeutics Inc (ACRV) in 2026 is set at an average of $10.86. Estimates vary from a peak of $20.31 to a trough of $1.4016, indicating an +38.64% surge from the present price of $7.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $7.3081 | $7.1118 | $6.5418 | -6.67% |
| February, 2026 | $6.5232 | $6.6232 | $6.0569 | -16.69% |
| March, 2026 | $8.0783 | $6.4194 | $6.9283 | +3.17% |
| April, 2026 | $11.39 | $8.4126 | $10.76 | +45.46% |
| May, 2026 | $11.70 | $10.92 | $10.88 | +49.49% |
| June, 2026 | $9.7498 | $10.48 | $11.03 | +24.52% |
| July, 2026 | $8.9712 | $9.4087 | $9.1824 | +14.57% |
| August, 2026 | $9.1263 | $9.3363 | $9.1909 | +16.56% |
| September, 2026 | $6.2277 | $6.7177 | $8.7626 | -20.46% |
| October, 2026 | $3.9628 | $5.1128 | $5.8083 | -49.39% |
| November, 2026 | $1.8379 | $1.4016 | $3.2091 | -76.53% |
| December, 2026 | $22.01 | $1.8004 | $20.31 | +181.08% |
Acrivon Therapeutics Inc Stock (ACRV) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Acrivon Therapeutics Inc (ACRV) is $19.55, with a high forecast of $23.76 and a low forecast of $15.34. This indicates an +149.69% increase from the last price of $7.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.17 | $22.47 | $23.76 | +170.33% |
| February, 2027 | $19.70 | $20.15 | $19.83 | +151.65% |
| March, 2027 | $17.08 | $19.23 | $19.25 | +118.09% |
| April, 2027 | $16.70 | $17.45 | $16.92 | +113.33% |
| May, 2027 | $15.89 | $16.74 | $16.17 | +102.96% |
| June, 2027 | $15.25 | $15.34 | $15.28 | +94.81% |
| July, 2027 | $18.28 | $15.93 | $16.13 | +133.48% |
| August, 2027 | $19.07 | $19.21 | $18.98 | +143.54% |
| September, 2027 | $18.73 | $18.92 | $18.73 | +139.22% |
| October, 2027 | $16.57 | $17.29 | $17.66 | +111.60% |
| November, 2027 | $15.99 | $16.20 | $16.10 | +104.17% |
| December, 2027 | $14.87 | $15.62 | $15.77 | +89.89% |
Acrivon Therapeutics Inc Stock (ACRV) Price Forecast for 2028
In 2028, Acrivon Therapeutics Inc (ACRV) is projected to reach an average price of $20.89, with a high projection of $35.12 and a low estimate of $6.6524. This indicates an +166.76% rise from the last price of $7.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $12.64 | $12.68 | $14.44 | +61.38% |
| February, 2028 | $9.8836 | $10.35 | $10.48 | +26.23% |
| March, 2028 | $6.064 | $6.6524 | $5.4757 | -22.55% |
| April, 2028 | $37.07 | $28.38 | $32.92 | +373.41% |
| May, 2028 | $30.37 | $31.50 | $35.12 | +287.87% |
| June, 2028 | $29.82 | $30.29 | $29.90 | +280.85% |
| July, 2028 | $27.60 | $27.80 | $28.83 | +252.50% |
| August, 2028 | $26.08 | $26.37 | $26.86 | +233.12% |
| September, 2028 | $24.89 | $26.30 | $25.52 | +217.93% |
| October, 2028 | $24.71 | $24.26 | $24.25 | +215.63% |
| November, 2028 | $27.69 | $25.64 | $26.88 | +253.60% |
| December, 2028 | $27.22 | $26.92 | $27.17 | +247.66% |
Acrivon Therapeutics Inc Stock (ACRV) Price Forecast for 2029
The 2029 price forecast for Acrivon Therapeutics Inc Stock (ACRV) is $29.09 on average, with a high prediction of $46.48 and a low estimate of $11.69. This represents an +271.49% increase from the previous price of $7.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $24.53 | $25.26 | $26.42 | +213.28% |
| February, 2029 | $23.37 | $23.52 | $23.59 | +198.47% |
| March, 2029 | $22.65 | $22.84 | $22.34 | +189.27% |
| April, 2029 | $20.78 | $21.22 | $21.81 | +165.39% |
| May, 2029 | $16.44 | $17.51 | $18.80 | +110.00% |
| June, 2029 | $11.61 | $11.90 | $14.92 | +48.32% |
| July, 2029 | $38.85 | $11.69 | $35.69 | +396.17% |
| August, 2029 | $44.56 | $45.52 | $46.48 | +469.14% |
| September, 2029 | $41.45 | $41.85 | $43.22 | +429.33% |
| October, 2029 | $39.22 | $39.97 | $40.65 | +400.89% |
| November, 2029 | $37.27 | $37.94 | $37.18 | +376.02% |
| December, 2029 | $35.90 | $36.00 | $35.67 | +358.43% |
Acrivon Therapeutics Inc Stock (ACRV) Price Forecast for 2030
Acrivon Therapeutics Inc Stock (ACRV) is expected to reach an average price of $37.24 in 2030, with a high forecast of $57.85 and a low forecast of $16.64. This signifies an +375.63% surge from the last price of $7.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $33.39 | $33.48 | $34.25 | +326.42% |
| February, 2030 | $33.50 | $33.18 | $33.07 | +327.86% |
| March, 2030 | $36.00 | $35.61 | $35.37 | +359.82% |
| April, 2030 | $35.10 | $34.93 | $35.18 | +348.24% |
| May, 2030 | $31.85 | $31.87 | $34.12 | +306.77% |
| June, 2030 | $29.61 | $30.41 | $30.74 | +278.20% |
| July, 2030 | $28.23 | $28.50 | $28.92 | +260.49% |
| August, 2030 | $24.12 | $24.61 | $27.13 | +208.04% |
| September, 2030 | $20.63 | $21.78 | $23.39 | +163.50% |
| October, 2030 | $16.15 | $17.05 | $19.57 | +106.20% |
| November, 2030 | $56.71 | $16.64 | $55.01 | +624.24% |
| December, 2030 | $54.64 | $55.94 | $57.85 | +597.87% |
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):